Showing results (111-120 of 186) with videos related to

Sort By:
Pageof 19
Plos One|January 31, 2025
A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone appFredrick Chite Asirwa, Brian W Bresnahan, Faith Yego, et al.
Diabetes Care|January 29, 2011
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatmentJennie H Best, Richard R Rubin, Mark Peyrot, et al.
Academic Radiology|April 2, 2017
Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected AppendicitisMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Academic Radiology|April 5, 2017
Toward a Framework for Benefit-Risk Assessment in Diagnostic Imaging: Identifying Scenario-specific CriteriaMaria Agapova, Brian W Bresnahan, Ken F Linnau, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]Darius N Lakdawalla, Jalpa A Doshi, Louis P Garrison, et al.
Transplantation and Cellular Therapy|June 26, 2023
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation PatientRichard T Maziarz, Steven Devine, Louis P Garrison, et al.
Therapeutic Advances in Cardiovascular Disease|December 25, 2015
The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approachJeffrey Chambers, Philippe Généreux, Arthur Lee, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part IILouis P Garrison, Edward C Mansley, Thomas A Abbott, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|May 15, 2012
Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington stateVincent W Lin, Andrew Wright, David R Flum, et al.
The Journal of Infectious Diseases|June 14, 2011
Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccinationLouis P Garrison, Chris T Bauch, Brian W Bresnahan, et al.
Pageof 19